Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 9 of 159
Pharmaceutical Business review is using cookies

ContinueLearn More

All articles by vbandhakavi 

Omeros gets FDA Orphan Drug Designation for PNH therapy

The investigational human monoclonal antibody, OMS906 targets mannan-binding lectin-associated serine protease-3 (MASP-3), the main activator of the alternative pathway of the complement system. MASP-3 converts pro-complement factor D